Discontinued — last reported Q3 '17
Frequent or large adjustments may signal operational instability or changing risk profiles within the segment.
This represents changes to accounting reserves or valuation allowances specifically for the pharmaceutical segment, such...
Comparable to 'Provision for bad debts' or 'Inventory reserve adjustments' across the pharmaceutical industry.
jnj_segment_pharmaceutical_valuation_allowances_and_reserves_adjustments